Literature DB >> 12401678

Evaluation of response: new and standard criteria.

P Therasse1.   

Abstract

Mesh：

Year:  2002        PMID： 12401678     DOI： 10.1093/annonc/mdf649

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  13 in total

Review 1.  [Significance of dendritic cells for the immunotherapy of tumors].

Authors:  J B Weise; S Maune; D Kabelitz; A Heiser
Journal:  HNO       Date:  2005-02       Impact factor: 1.284

2.  Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.

Authors:  Qizhe Sun; Wenli Ma; Yuan Gao; Wenling Zheng; Bao Zhang; Yifei Peng
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-12-29

3.  A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.

Authors:  Simon Pacey; Martin Gore; David Chao; Udai Banerji; James Larkin; Sarah Sarker; Karen Owen; Yasmin Asad; Florence Raynaud; Mike Walton; Ian Judson; Paul Workman; Tim Eisen
Journal:  Invest New Drugs       Date:  2010-08-05       Impact factor: 3.850

4.  Time course of imaging changes of GBM during extended bevacizumab treatment.

Authors:  Suchitra Ananthnarayan; Jennie Bahng; James Roring; Phioanh Nghiemphu; Albert Lai; Timothy Cloughesy; Whitney B Pope
Journal:  J Neurooncol       Date:  2008-04-04       Impact factor: 4.130

5.  Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.

Authors:  Saby George; Robert Dreicer; Jessie J L Au; Tong Shen; Brian I Rini; Susan Roman; Matthew M Cooney; Tarek Mekhail; Paul Elson; Guillaume M Wientjes; Ram Ganapathi; Ronald M Bukowski
Journal:  Clin Genitourin Cancer       Date:  2008-09       Impact factor: 2.872

6.  Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.

Authors:  Susanne Blank; Florian Lordick; Franz Bader; Maria Burian; Martin Dobritz; Lars Grenacher; Karen Becker; Wilko Weichert; Rupert Langer; Leila Sisic; Annika Stange; Dirk Jäger; Markus Büchler; Thomas Bruckner; Jörg Siewert; Katja Ott
Journal:  Gastric Cancer       Date:  2014-04-11       Impact factor: 7.370

7.  A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors.

Authors:  Simon Pacey; Richard H Wilson; Mike Walton; Martin M Eatock; Anthea Hardcastle; Anna Zetterlund; Hendrik-Tobias Arkenau; Javier Moreno-Farre; Udai Banerji; Belle Roels; Heidi Peachey; Wynne Aherne; Johan S de Bono; Florence Raynaud; Paul Workman; Ian Judson
Journal:  Clin Cancer Res       Date:  2011-01-28       Impact factor: 12.531

8.  Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Authors:  Yin-Kai Chao; Chi-Ju Yeh; Mu-Hsien Lee; Yu-Wen Wen; Hsien-Kun Chang; Chen-Kan Tseng; Yun-Hen Liu
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

9.  Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Fan Cheung; Xuanbin Wang; Ning Wang; Man-Fung Yuen; Tat-Chi Ziea; Yao Tong; Vivian Taam Wong; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-17       Impact factor: 2.629

10.  Role of everolimus in the treatment of renal cell carcinoma.

Authors:  Saby George; Ronald M Bukowski
Journal:  Ther Clin Risk Manag       Date:  2009-09-15       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.